Jan 31, 2022

Featuring an interview with Dr Saad Zafar Usmani, including the following topics:

• Determining transplant eligibility for patients with newly diagnosed multiple myeloma (MM); treatment for transplant-eligible patients who decline transplant (0:00)
• Assessing frailty in patients with MM; underrepresentation of older...

Jan 28, 2022

Featuring perspectives from Dr Ruth O’Regan, including the following topics:

• Introduction (0:00)
• Case: A woman in her late 40s with an ER/PR-positive, HER2-negative, node-negative invasive ductal carcinoma (IDC) — Laila Agrawal, MD (5:09)
• Case: A woman in her mid-40s with ER/PR-positive, HER2-negative mBC — Raman...

Jan 26, 2022

Featuring perspectives from Dr Naval Daver, including the following topics:

• Introduction (0:00)
• Case: A man in his late 70s with acute myeloid leukemia (AML) and a TP53 mutation — Shaachi Gupta, MD, MPH (22:20)
• Case: A woman in her early 40s with relapsed AML — Rebecca L Olin, MD, MSCE (27:34)
• Case: A woman in her...

Jan 24, 2022

Featuring perspectives from Dr Jeremy Abramson, Professor Martin Dreyling, Dr Loretta Nastoupil and Dr Gilles Salles, moderated by Dr Ann LaCasce, including the following topics:

• Introduction (0:00)
• Diffuse Large B-Cell Lymphoma (2:40)
• Follicular Lymphoma (26:12)
• Mantle Cell Lymphoma (48:44)
• Current and Potential Role...

Jan 24, 2022

Featuring perspectives from Drs Larry Anderson Jr, Morie Gertz, Irene Ghobrial and Peter Voorhees, moderated by Dr Robert Orlowski, including the following topics:

• Introduction (0:00)
• Contemporary Treatment Planning for Patients with Newly Diagnosed Multiple Myeloma (MM) (4:21)
• Chimeric Antigen Receptor T-Cell Therapy...